1. Debigare R, Cote CH, Maltais F. (2010). Ubiquitination and proteolysis in limb and respiratory muscles of patients with chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society 7(1):84-90.
2. Vieira DS, Maltais F, Bourbeau J. (2010). Home-based pulmonary rehabilitation in chronic obstructive pulmonary disease patients. Current Opinion in Pulmonary Medicine 16(2):134-43.
3. Marquis K, Maltais F, Lacasse Y, Lacourciere Y, et al. (2008). Effects of aerobic exercise training and irbesartan on blood pressure and heart rate variability in patients with chronic obstructive pulmonary disease. Canadian Respiratory Journal 15(7):355-60.
4. Maltais F, Bourbeau J, Shapiro S, Lacasse Y, et al. (2008). Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial.[summary for patients in Ann Intern Med 2008 Dec 16;149(12):I56; PMID: 19075202]. Annals of Internal Medicine 149(12):869-78.
5. Maltais F, Bourbeau J, Shapiro S, Lacasse Y, et al. (2008). Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: A randomized trial. Annals of Internal Medicine 149(12):869-878.
6. Debigare R, Maltais F, Cote CH, Michaud A, et al. (2008). Profiling of mRNA expression in quadriceps of patients with COPD and muscle wasting. COPD: Journal of Chronic Obstructive Pulmonary Disease 5(2).
7. Debigare R, Maltais F. (2008). The major limitation to exercise performance in COPD is lower limb muscle dysfunction. Journal of Applied Physiology 105(2):751-3; discussion 755-7.
8. Marquis K, Maltais F, Poirier P. (2008). [Cardiovascular manifestations in patients with COPD]. Revue des Maladies Respiratoires 25(6):663-73.
9. Vivodtzev I, Lacasse Y, Maltais F. (2008). Neuromuscular electrical stimulation of the lower limbs in patients with chronic obstructive pulmonary disease. Journal of Cardiopulmonary Rehabilitation and Prevention 28(2):79-91.
10. Lessard A, Maltais F, Boulet LP. (2008). Clinical management of chronic obstructive pulmonary disease and asthma in an obese patient. Expert Opinion on Pharmacotherapy 9(1):83-93.
